Your browser doesn't support javascript.
loading
Therapeutic Targeting of Nuclear γ-Tubulin in RB1-Negative Tumors.
Lindström, Lisa; Villoutreix, Bruno O; Lehn, Sophie; Hellsten, Rebecka; Nilsson, Elise; Crneta, Enisa; Olsson, Roger; Alvarado-Kristensson, Maria.
  • Lindström L; Molecular Pathology, Department of Translational Medicine, Lund University, Skåne University Hospital, Malmö, Sweden.
  • Villoutreix BO; Université Paris Diderot, Sorbonne Paris Cité, UMRS 973 Inserm, Paris, France. Inserm, U973, Paris, France.
  • Lehn S; Molecular Pathology, Department of Translational Medicine, Lund University, Skåne University Hospital, Malmö, Sweden.
  • Hellsten R; Division of Urological Cancers, Lund University, Skåne University Hospital, Malmö, Sweden.
  • Nilsson E; Molecular Pathology, Department of Translational Medicine, Lund University, Skåne University Hospital, Malmö, Sweden.
  • Crneta E; Molecular Pathology, Department of Translational Medicine, Lund University, Skåne University Hospital, Malmö, Sweden.
  • Olsson R; Chemical Biology and Therapeutics, Department of Experimental Medical Science, BMC, Lund University, Lund, Sweden.
  • Alvarado-Kristensson M; Molecular Pathology, Department of Translational Medicine, Lund University, Skåne University Hospital, Malmö, Sweden. maria.alvarado-kristensson@med.lu.se.
Mol Cancer Res ; 13(7): 1073-82, 2015 Jul.
Article en En | MEDLINE | ID: mdl-25934692

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tubulina (Proteína) / Proteínas Nucleares / Monoterpenos / Moduladores de Tubulina / Acetales / Microtúbulos / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Año: 2015 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tubulina (Proteína) / Proteínas Nucleares / Monoterpenos / Moduladores de Tubulina / Acetales / Microtúbulos / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Año: 2015 Tipo del documento: Article